|
|
Volumn 101, Issue 10, 2009, Pages 704-706
|
|
Federal task force seeks standards for immunotherapy biomarker studies
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
INTERLEUKIN 2;
BIOLOGICAL THERAPY;
CANCER CELL;
CANCER IMMUNOTHERAPY;
CANCER PATIENT;
CLINICAL RESEARCH;
COMMUNITY;
COST;
GOVERNMENT;
IMMUNE RESPONSE;
MEDICAL INFORMATION;
NOTE;
PRIORITY JOURNAL;
SURVIVAL;
ADVISORY COMMITTEE;
CLINICAL TRIAL;
HUMAN;
IMMUNOTHERAPY;
METHODOLOGY;
NEOPLASM;
ONCOLOGY;
STANDARD;
UNITED STATES;
ADVISORY COMMITTEES;
BIOLOGICAL MARKERS;
CLINICAL TRIALS AS TOPIC;
HUMANS;
IMMUNOTHERAPY;
MEDICAL ONCOLOGY;
NEOPLASMS;
RESEARCH DESIGN;
UNITED STATES;
|
|
EID: 66849083675
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djp135 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|